CHARACTERISTICS | SURVIVORS (N = 1157*), N (%) |
---|---|
Age at diagnosis, y | |
• 0–4 | 404 (35.0) |
• 5–9 | 217 (18.8) |
• 10–14 | 218 (18.9) |
• 15–19 | 315 (27.3) |
Time since diagnosis, y | |
• 5–9 | 194 (16.9) |
• 10–14 | 377 (32.9) |
• 15–19 | 283 (24.7) |
• 20–24 | 188 (16.4) |
• ≥ 25 | 103 (9.0) |
Diagnosis | |
• ALL | 242 (20.9) |
• Other leukemia | 30 (2.6) |
• Hodgkins lymphoma | 135 (11.7) |
• Non-Hodgkins lymphoma | 65 (5.6) |
• CNS tumour | 229 (19.8) |
• Renal tumour | 73 (6.3) |
• Bone tumour | 52 (4.5) |
• Carcinomas | 102 (8.8) |
• Other | 229 (19.8) |
Period of diagnosis | |
• 1970–1980 (11 y) | 259 (22.4) |
• 1981–1990 (10 y) | 618 (53.4) |
• 1991–1995 (6 y) | 280 (24.2) |
Treatment | |
• Surgery only | 243 (21.0) |
• Radiation only | 46 (4.0) |
• Chemotherapy only | 194 (16.8) |
• Chemotherapy and surgery | 150 (13.0) |
• Chemotherapy and radiation | 208 (18.0) |
• Radiation and surgery | 138 (11.9) |
• Chemotherapy, radiation, and surgery | 105 (9.1) |
• Unknown | 73 (6.3) |
ALL—acute lymphoblastic leukemia, CNS—central nervous system.
↵* Data were not available for all survivors for all characteristics.